The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Cocirculation of two distinct evolutionary lineages of influenza type B virus since 1983
Abstract
During 1988-1989 two highly distinct antigenic variants of influenza type B were recognized in hemagglutination-inhibition tests with postinfection ferret serum. These viruses were antigenically related to either B/Victoria/2/87, the most recent reference strain, or B/Yamagata/16/88, a variant that was isolated in Japan in May 1988. All influenza B viruses isolated in the United States during an epidemic in the winter of 1988-1989 were antigenically related to B/Victoria/2/87. However, in several countries in Asia, both B/Victoria/2/87-like viruses and B/Yamagata/16/88-like viruses were isolated. Sequence analysis of the hemagglutinin (HA) genes of several influenza B isolates from 1987 to 1988 indicated that the HA1 domains of the B/Yamagata/16/88-like viruses and B/VI/87-like viruses isolated in 1988 differed by 27 amino acids. Evolutionary relationships based on this sequence data indicated that the B/Yamagata/16/88-like viruses were more closely related to epidemic viruses from 1983 (B/USSR/100/83-like viruses) than to more recent reference strains such as B/Victoria/2/87. All other Asian strains, as well as selected isolates from the United States in 1988, were confirmed by sequence analysis as being genetically related to B/Victoria/2/87. These data provide clear evidence that two parallel evolutionary pathways of influenza type B have existed since at least 1983 and that viruses from each of the separate lineages were isolated from cases of influenza B in 1988. This finding is similar to earlier observations for type A H1N1 and H3N2 influenza viruses.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The time from onset to death observed with fatal influenza B was more rapid than the duration of fatal illness described for pandemic 1918 A(H1N1), pandemic 1957 A(H2N2), pandemic 1968 A(H3N2), pandemic 2009 H1N1, and seasonal A(H3N2) viruses [3, 10-13, 4).”
From Myocardial Injury and Bacterial Pneumonia Contribute to the Pathogenesis of Fatal Influenza B Virus Infection (2012) · cites this paper as [4]
Citations
Cites
DNA sequencing with chain-terminating inhibitors
Sanger, F., Nicklen, S., & Coulson, A. R. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.12.5463 · Cited by 68,572
A comprehensive set of sequence analysis programs for the VAX
Devereux, J., Haeberli, P. E., & Smithies, O. (1984) · Nucleic Acids Research · doi:10.1093/nar/12.1part1.387 · Cited by 14,222
Wiley, D. C., Wilson, I. A., & Skehel, J. J. (1981) · Nature · doi:10.1038/289373a0 · Cited by 1,623
THE STRUCTURE AND FUNCTION OF THE HEMAGGLUTININ MEMBRANE GLYCOPROTEIN OF INFLUENZA VIRUS
Wiley, D. C., & Skehel, J. J. (1987) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.56.070187.002053 · Cited by 1,413
The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype)
Caton, A. J., Brownlee, G. G., Yewdell, J. W., & Gerhard, W. (1982) · Cell · doi:10.1016/0092-8674(82)90135-0 · Cited by 1,036
Both, G. W., Sleigh, M. J., Cox, N. J., & Kendal, A. P. (1983) · Journal of Virology · doi:10.1128/jvi.48.1.52-60.1983 · Cited by 327
Geographic distribution of wild poliovirus type 1 genotypes
Rico-Hesse, R., Pallansch, M. A., Nottay, B. K., & Kew, O. M. (1987) · Virology · doi:10.1016/0042-6822(87)90001-8 · Cited by 327
Evidence for host-cell selection of influenza virus antigenic variants
Schild, G. C., OXFORD, J. S., de Jong, J. C., & Webster, R. G. (1983) · Nature · doi:10.1038/303706a0 · Cited by 314
Evolution of Human Influenza A Viruses Over 50 Years: Rapid, Uniform Rate of Change in NS Gene
Buonagurio, D. A., Nakada, S., Parvin, J. D., Krystal, M., Palese, P., & Fitch, W. M. (1986) · Science · doi:10.1126/science.2939560 · Cited by 288
Differences in RNA patterns of influenza A viruses
Palese, P., & Schulman, J. L. (1976) · Journal of Virology · doi:10.1128/jvi.17.3.876-884.1976 · Cited by 223
Research works printed but not linked: 1
- World Health Organization, 1989, Recommended composition of influenza virus vaccine for use in the 1989–1990 season, WHO Weekly Epidemiol Rec., 8, 53
Cited by
Sorted by citations
Items 201–300 of 540
Montomoli, E., Torelli, A., Manini, I., & Gianchecchi, E. (2018) · Vaccines · doi:10.3390/vaccines6010014 · Cited by 26
Host Receptors of Influenza Viruses and Coronaviruses—Molecular Mechanisms of Recognition
Sriwilaijaroen, N., & Suzuki, Y. (2020) · Vaccines · doi:10.3390/vaccines8040587 · Cited by 26
Zhao, B., Qin, S., Teng, Z., Chen, J., Yu, X., Gao, Y., Shen, J., Cui, X., Zeng, M., & Zhang, X. (2015) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2015.03.009 · Cited by 24
Fang, Q., Gao, Y., Chen, M., Guo, X., Yang, X., & Wei, L. (2015) · Archives of Virology · doi:10.1007/s00705-015-2362-x · Cited by 24
Influenza B viruses in pigs, Taiwan
Tsai, C., & Tsai, H. (2018) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.12588 · Cited by 24
Multi-Lineage Evolution in Viral Populations Driven by Host Immune Systems
Marchi, J., Lässig, M., Mora, T., & Walczak, A. M. (2019) · Pathogens · doi:10.3390/pathogens8030115 · Cited by 24
Influenza B: Prospects for the Development of Cross-Protective Vaccines
Tsybalova, L. M., Stepanova, L. A., Ramsay, E. S., & Vasin, A. V. (2022) · Viruses · doi:10.3390/v14061323 · Cited by 24
Fernandes, N. D., & Downard, K. M. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.02315-13 · Cited by 25
Sakai, K., Ami, Y., Nakajima, N., Nakajima, K., Kitazawa, M., Anraku, M., Takayama, I., Sangsriratanakul, N., Komura, M., Sato, Y., et al. (2016) · Scientific Reports · doi:10.1038/srep29430 · Cited by 24
Evolutionary dynamic of antigenic residues on influenza B hemagglutinin
Suptawiwat, O., Ninpan, K., Boonarkart, C., Ruangrung, K., & Auewarakul, P. (2016) · Virology · doi:10.1016/j.virol.2016.12.015 · Cited by 24
Георгиевна, Р. Л., Kiseleva, I., Krutikova, E. V., Stepanova, E., Rekstin, A. R., Donina, S., Pisareva, M., Grigorieva, E., Kryshen, K. L., Muzhikyan, A., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0208028 · Cited by 24
Characterization of the epidemic influenza B viruses isolated during 2004–2005 season in Taiwan
Lin, J., Chiu, S., Shaw, M. W., Lin, Y.-C., Lee, C.-H., Chen, H.-Y., & Klimov, A. I. (2006) · Virus Research · doi:10.1016/j.virusres.2006.11.005 · Cited by 24
Mutational pattern of influenza B viruses adapted to high growth replication in embryonated eggs
Lugovtsev, V. Y., Vodeiko, G. M., & Levandowski, R. A. (2004) · Virus Research · doi:10.1016/j.virusres.2004.11.016 · Cited by 24
Emergence of an Influenza B Virus with Antigenic Change
Nakagawa, N., Nukuzuma, S., Haratome, S., Go, S., Nakagawa, T., & Hayashi, K. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.8.3068-3070.2002 · Cited by 24
Getting the flu: 5 key facts about influenza virus evolution
Johnson, K., Song, T., Greenbaum, B. D., & Ghedin, E. (2017) · PLoS Pathogens · doi:10.1371/journal.ppat.1006450 · Cited by 23
Molecular Basis of mRNA Cap Recognition by Influenza B Polymerase PB2 Subunit
Xie, L., Wartchow, C. A., Shia, S., Uehara, K., Steffek, M., Warne, R. L., Sutton, J. C., Muiru, G. T., Léonard, V. H. J., Bussiere, D. E., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.693051 · Cited by 23
Evaluating the case for trivalent or quadrivalent influenza vaccines
Baxter, D. N. (2016) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2015.1091130 · Cited by 23
Nakagawa, N., Kubota, R., Maeda, A., & Okuno, Y. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.7.3295-3297.2004 · Cited by 23
Kinnunen, L., Ikonen, N., Pöyry, T. A. A., & Pyhälä, R. (1992) · Journal of General Virology · doi:10.1099/0022-1317-73-3-733 · Cited by 23
Sesay, S., Brzostek, J., Meyer, I., Donazzolo, Y., Leroux-Roels, G. G., Rouzier, R., Astruc, B., Szymański, H., Toursarkissian, N., Vandermeulen, C., et al. (2017) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2017.1384106 · Cited by 22
Kim, Y., Bang, Y., Park, H., Ko, H. L., Park, S., Hwang, K.-A., Kim, H., & Nam, J. (2020) · Vaccine · doi:10.1016/j.vaccine.2020.07.022 · Cited by 22
Diagnosis of Influenza from Respiratory Autopsy Tissues
Denison, A. M., Blau, D. M., Jost, H. A., Jones, T., Rollin, D., Gao, R., Liu, L., Bhatnagar, J., DeLeon-Carnes, M., Shieh, W., et al. (2011) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2010.09.004 · Cited by 22
Development of an Alternative Modified Live Influenza B Virus Vaccine
Santos, J. J. D. S., Finch, C. L., Sutton, T. C., Obadan, A. O., Aguirre, I., Wan, Z., Lopez, D., Geiger, G., Gonzalez-Reiche, A. S., Ferreri, L. M., et al. (2017) · Journal of Virology · doi:10.1128/jvi.00056-17 · Cited by 22
Hutchinson, E. C., & Yamauchi, Y. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-8678-1_1 · Cited by 24
Jian, J.-W., Lai, C., Kuo, C., Kuo, S. H.-S., Hsu, L., Chen, P., Wu, H.-S., & Liu, M.-T. (2007) · Virus Research · doi:10.1016/j.virusres.2007.09.014 · Cited by 22
Mixed populations in influenza virus vaccine strains
Robertson, J. S., Cook, P., Nicolson, C., Newman, R. W., & Wood, J. (1994) · Vaccine · doi:10.1016/s0264-410x(94)80058-8 · Cited by 21
Trucchi, C., Alicino, C., Orsi, A., Paganino, C., Barberis, I., Grammatico, F., Canepa, P., Rappazzo, E., Bruzzone, B. M., Sticchi, L., et al. (2016) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2017.1264779 · Cited by 21
Molecular Markers of Influenza B Lineages and Clades
Arvia, R., Corcioli, F., Pierucci, F., & Azzi, A. (2014) · Viruses · doi:10.3390/v6114437 · Cited by 21
Development of high-yield influenza B virus vaccine viruses
Ping, J., Lopes, T. J. S., Neumann, G., & Kawaoka, Y. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1616530113 · Cited by 21
Universal influenza virus vaccines: what needs to happen next?
Trucchi, C., Paganino, C., Amicizia, D., Orsi, A., Tisa, V., Piazza, M. F., Icardi, G., & Ansaldi, F. (2019) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2019.1604671 · Cited by 21
Pyhälä, R., Kleemola, M., Kumpulainen, V., Vartiainen, E. A., LAPPI, S., Pönkä, A., & Cantell, K. (1992) · Vaccine · doi:10.1016/0264-410x(92)90446-q · Cited by 21
Quasispecies Dynamics and Evolution of Foot-and-Mouth Disease Virus
Ruiz-Jarabo, C. M., Domingo, E., García‐Arriaza, J., Arias, A., & Escarmı́s, C. (2004) · CRC Press eBooks · doi:10.1201/9781420037968.ch10 · Cited by 21
Influenza infection in human host: challenges in making a better influenza vaccine
Virk, R. K., Gunalan, V., & Tambyah, P. A. (2016) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2016.1155450 · Cited by 20
Broadly Neutralizing Antibodies for Influenza: Passive Immunotherapy and Intranasal Vaccination
Biswas, M., Yamazaki, T., Chiba, J., & Akashi‐Takamura, S. (2020) · Vaccines · doi:10.3390/vaccines8030424 · Cited by 22
Marchi, S., Fallani, E., Salvatore, M., Montomoli, E., & Trombetta, C. M. (2023) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2023.2257048 · Cited by 20
In silico design of a broad-spectrum multiepitope vaccine against influenza virus
Yuan, L., Li, X., Li, M., Bi, R., Li, Y., Song, J., Li, W., Yan, M., Luo, H., Sun, C., et al. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.128071 · Cited by 20
A broad-spectrum multiepitope vaccine against seasonal influenza A and B viruses in mice
Yuan, L., Zhang, S., Bi, R., Liu, X., Han, Z., Li, M., Liao, X., Xie, T., Bai, S., Xie, Q., et al. (2024) · EBioMedicine · doi:10.1016/j.ebiom.2024.105269 · Cited by 20
Proteotyping to establish the lineage of type A H1N1 and type B human influenza virus
Schwahn, A. B., & Downard, K. M. (2010) · Journal of Virological Methods · doi:10.1016/j.jviromet.2010.10.011 · Cited by 20
Influenza vaccination in preventing outbreaks in schools: A long-term ecological overview
Pan, Y., Wang, Q., Yang, P., Zhang, L., Wu, S., Zhang, Y., Sun, Y., Duan, W., Ma, C., Zhang, M., et al. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.10.096 · Cited by 20
de Paiva, T. M., Benega, M. A., Silva, D. B. B., Santos, K. C. O., Cruz, Á. S., Hortenci, M. F., Barbieri, M. T., Monteiro, M. M., Barbosa, H. A., & Carvalhanas, T. R. M. P. (2013) · Journal of Medical Virology · doi:10.1002/jmv.23684 · Cited by 19
Evidence update: GlaxoSmithKline’s inactivated quadrivalent influenza vaccines
Bekkat-Berkani, R., Ray, R., Jain, V. K., Chandrasekaran, V., & Innis, B. L. (2015) · Expert Review of Vaccines · doi:10.1586/14760584.2016.1113878 · Cited by 19
Furuse, Y., Matsuzaki, Y., Nishimura, H., & Oshitani, H. (2016) · Viruses · doi:10.3390/v8120321 · Cited by 20
Verma, S., Soto, J., Vasudevan, A., Schmeisser, F., Alvarado-Facundo, E., Wang, W., Weiss, C. D., & Weir, J. P. (2017) · PLoS ONE · doi:10.1371/journal.pone.0175733 · Cited by 19
Native Human Monoclonal Antibodies with Potent Cross-Lineage Neutralization of Influenza B Viruses
Vigil, A., Estellés, A., Kauvar, L. M., Johnson, S. K., Tripp, R. A., & Wittekind, M. G. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02269-17 · Cited by 19
Cross-Reactive and Lineage-Specific Single Domain Antibodies against Influenza B Hemagglutinin
Ramage, W., Gaiotto, T., Ball, C., Risley, P., Carnell, G., Temperton, N. J., Cheung, C. Y., Engelhardt, O. G., & Hufton, S. E. (2019) · Antibodies · doi:10.3390/antib8010014 · Cited by 19
Nguyen, V. H., Vizzotti, C., Urueña, A., Giglio, N., Magneres, C., & Richmond, H. (2020) · Vaccine · doi:10.1016/j.vaccine.2020.02.081 · Cited by 19
Detection sensitivity of influenza rapid diagnostic tests
Sakai‐Tagawa, Y., Ozawa, M., Yamada, S., Uchida, Y., Saito, T., Takahashi, K., Sugaya, N., Tashiro, M., & Kawaoka, Y. (2014) · Microbiology and Immunology · doi:10.1111/1348-0421.12185 · Cited by 18
Relative timing of influenza disease by age group
Peters, T. R., Snively, B. M., Suerken, C. K., Blakeney, E. S., Vannoy, L., & Poehling, K. A. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.09.047 · Cited by 18
Ferrara, F., Rosario, J. M. M. D., da Costa, K. A. S., Kinsley, R., Scott, S. D., Fereidouni, S. R., Thompson, C., Kellam, P., Gilbert, S. C., Carnell, G., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.661379 · Cited by 18
Approaches for discovery of small-molecular antivirals targeting to influenza A virus PB2 subunit
Chen, W., Shao, J., Ying, Z., Du, Y., & Yu, Y. (2022) · Drug Discovery Today · doi:10.1016/j.drudis.2022.02.024 · Cited by 18
Wilson, J. L., Akin, E. H., Zhou, R., Jedlicka, A., Dziedzic, A., Liu, H., Fenstermacher, K., Rothman, R. E., & Pekosz, A. S. (2023) · Viruses · doi:10.3390/v15091956 · Cited by 18
Vodeiko, G. M., McInnis, J., Chizhikov, V., & Levandowski, R. A. (2003) · Vaccine · doi:10.1016/s0264-410x(03)00312-8 · Cited by 18
Influenza B Virus With Modified Hemagglutinin Cleavage Site as a Novel Attenuated Live Vaccine
Stech, J., Garn, H., Herwig, A., Stech, O., Dauber, B., Wolff, T., Mettenleiter, T. C., & Klenk, H. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir613 · Cited by 18
Hospital-based vaccine effectiveness against influenza B lineages, Hong Kong, 2009−14
Chiu, S. S. S., Feng, S., Chan, K., Lo, J., Chan, E. L. Y., So, L., Cowling, B. J., & Peiris, M. J. S. (2016) · Vaccine · doi:10.1016/j.vaccine.2016.03.032 · Cited by 18
Weber, M., Claeys, C., Doniz, C. A., Feng, Y., Innis, B. L., Jain, V. K., & Peeters, M. (2014) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000000463 · Cited by 18
Belazi, S., Olsen, S. J., Brown, C., Green, H. K., Mook, P. A., Nguyen‐Van‐Tam, J. S., Penttinen, P. M., & Lansbury, L. (2021) · Eurosurveillance · doi:10.2807/1560-7917.es.2021.26.39.2000343 · Cited by 18
Functionality of the putative surface glycoproteins of the Wuhan spiny eel influenza virus
Arunkumar, G. A., Bhavsar, D., Li, T., Strohmeier, S., Chromikova, V., Amanat, F., Bunyatov, M. I., Wilson, P. C., Ellebedy, A. H., Boons, G., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26409-2 · Cited by 18
Nakagawa, N., Kubota, R., & Okuno, Y. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.8.4212-4214.2005 · Cited by 18
Elderfield, R. A., Koutsakos, M., Frise, R., Bradley, K. C., Ashcroft, J., Miah, S., Lackenby, A., & Barclay, W. (2015) · Journal of General Virology · doi:10.1099/jgv.0.000386 · Cited by 18
Influenza B burden during seasonal influenza epidemics in France
Mosnier, A., Daviaud, I., Casalegno, J., Ruetsch, M., Burugorri, C., Nauleau, E., Bui, T. T., Fleury, H. J., Lina, B., van der Werf, S., et al. (2017) · Médecine et Maladies Infectieuses · doi:10.1016/j.medmal.2016.11.006 · Cited by 17
Clark, T. W., Tregoning, J. S., Fisher, H. R., Poletti, T., Amin, F., & Nguyen‐Van‐Tam, J. S. (2024) · Clinical Microbiology Reviews · doi:10.1128/cmr.00025-24 · Cited by 17
Epidemiology of pandemic influenza A/H1N1 virus during 2009–2010 in Taiwan
Lan, Y., Su, M.-C., Chen, C., Huang, S.-H., Chen, W.-L., Tien, N., & Lin, C. (2013) · Virus Research · doi:10.1016/j.virusres.2013.07.007 · Cited by 17
Ikonen, N., Pyhälä, R., AXELIN, T., Kleemola, M., & KORPELA, H. (2005) · Epidemiology and Infection · doi:10.1017/s0950268804003462 · Cited by 17
Cowling, B. J., Wu, P., Lo, J., Chan, K., Chan, E. L. Y., Fang, V. J., So, L., Peiris, M. J. S., & Chiu, S. S. S. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix312 · Cited by 17
van de Witte, S., Nauta, J. J. P., Montomoli, E., & Weckx, J. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.04.043 · Cited by 17
The Development and Use of Reporter Influenza B Viruses
Dumm, R. E., & Heaton, N. S. (2019) · Viruses · doi:10.3390/v11080736 · Cited by 17
Luo, C., Morishita, T., Satou, K., Tateno, Y., Nakajima, K., & Nobusawa, E. (1999) · Archives of Virology · doi:10.1007/s007050050712 · Cited by 17
Antigenic and genetic analyses of influenza B viruses\\ isolated in Lusaka, Zambia in 1999
Muyanga, J., Matsuzaki, Y., Sugawara, K., Kimura, K., Mizuta, K., Ndumba, I., Muraki, Y., Tsuchiya, E., Hongo, S., Kasolo, F. C., et al. (2001) · Archives of Virology · doi:10.1007/s007050170055 · Cited by 17
Nakagawa, N., Kubota, R., Morikawa, S., Nakagawa, T., Baba, K., & Okuno, Y. (2001) · Journal of Medical Virology · doi:10.1002/jmv.2099 · Cited by 17
Zhang, N., Fang, S., Wang, T., Li, J., Cheng, X., Zhao, C., Wang, X., Lv, X., Wu, C., Zhang, R., et al. (2011) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-011-3710-8 · Cited by 16
Quinn, E., Jit, M., & Newall, A. T. (2014) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/14737167.2014.908713 · Cited by 16
Dela-Moss, L. I., Moss, W. N., & Turner, D. H. (2014) · BMC Research Notes · doi:10.1186/1756-0500-7-22 · Cited by 20
Zhu, D., Lok, C., Chao, S., Chen, L., Li, R., Zhao, Z., Dong, J., Qin, K., & Zhao, X. (2019) · Archives of Virology · doi:10.1007/s00705-019-04160-w · Cited by 16
Lei, N., Wang, H., Zhang, Y., Zhao, J., 田中, 義., Wang, Y., Huang, L., Ma, J., Sun, Q., Yang, L., et al. (2019) · Scientific Reports · doi:10.1038/s41598-018-38105-1 · Cited by 16
Boccalini, S., Bechini, A., Innocenti, M., Sartor, G., Manzi, F., Bonanni, P., Panatto, D., Lai, P. L., Zangrillo, F., Rizzitelli, E., et al. (2018) · PubMed Central · Cited by 16
Comparison of the HA genes of type B influenza viruses in herald waves and later epidemic seasons
Nakajima, S., NISHIKAWA, F., Nakamura, K., & Nakajima, K. (1992) · Epidemiology and Infection · doi:10.1017/s0950268800050548 · Cited by 16
Keresztes, G., Baer, M., Alfenito, M. R., Verwoerd, T. C., Kovalchuk, A., Wiebe, M. G., Andersen, T. K., Saloheimo, M., Tchelet, R., Kensinger, R. D., et al. (2022) · Vaccines · doi:10.3390/vaccines10020148 · Cited by 15
Pekarek, M. J., & Weaver, E. A. (2023) · Viruses · doi:10.3390/v15102032 · Cited by 14
Fluarix quadrivalent vaccine for influenza
de Graaf, H., & Faust, S. N. (2015) · Expert Review of Vaccines · doi:10.1586/14760584.2015.1057573 · Cited by 15
Carnell, G., Trombetta, C. M., Ferrara, F., Montomoli, E., & Temperton, N. J. (2021) · Vaccines · doi:10.3390/vaccines9020100 · Cited by 15
Weber, J., Prud’homme, I., & Zou, S. (1997) · Virus Genes · doi:10.1023/a:1007927725332 · Cited by 15
Venkatramani, L., Johnson, E. S., Kolavi, G. D., Air, G. M., Brouillette, W. J., & Mooers, B. H. M. (2012) · BMC Structural Biology · doi:10.1186/1472-6807-12-7 · Cited by 14
Kim, J. I., Lee, I., Park, S., Bae, J., Yoo, K., Lemey, P., Park, M. S., Song, J., Kee, S., Song, K., et al. (2016) · Scientific Reports · doi:10.1038/srep27480 · Cited by 14
Quadrivalent influenza vaccine in the United States
Suryadevara, M., & Domachowske, J. B. (2013) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.27115 · Cited by 14
Oong, X. Y., Ng, K. T., Tan, J. L., Chan, K., Kamarulzaman, A., Chan, Y. F., Sam, I., & Tee, K. K. (2017) · PLoS ONE · doi:10.1371/journal.pone.0170610 · Cited by 14
Predominance of influenza B/Yamagata lineage viruses in Bulgaria during the 2017/2018 season
Korsun, N., Angelova, S. G., Trifonova, I. T., Georgieva, I., Tzotcheva, I. S., Mileva, S., Voleva, S., Kurchatova, A., & Perenovska, P. (2019) · Epidemiology and Infection · doi:10.1017/s0950268818003588 · Cited by 14
Moser, M. J., Hatta, Y., Gabaglia, C. R., Sánchez, A., Dias, P. B., Sarawar, S. R., Kawaoka, Y., Hatta, M., Neumann, G., & Bilsel, P. (2019) · Vaccine · doi:10.1016/j.vaccine.2019.06.043 · Cited by 14
Catani, J. P. P., Ysenbaert, T., Smet, A., Vuylsteke, M., Vogel, T. U., & Saelens, X. (2023) · PLoS ONE · doi:10.1371/journal.pone.0280825 · Cited by 13
CD8+ T-cell responses towards conserved influenza B virus epitopes across anatomical sites and age
Menon, T., Illing, P. T., Chaurasia, P., McQuilten, H. A., Shepherd, C. M., Rowntree, L. C., Petersen, J., Littler, D. R., Khuu, G., Huang, Z., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-47576-y · Cited by 13
van der Vries, E., Ip, D., Cowling, B. J., Zhang, J. D., Tong, X., Wojtowicz, K., Schutten, M., & Boucher, C. A. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv375 · Cited by 13
Pan, Y., Zhang, Y., Yang, P., Qian, H., Shi, W., Wu, S., Cui, S., Zhang, D., & Wang, Q. (2015) · Medicine · doi:10.1097/md.0000000000002399 · Cited by 13
Epidemiology and Genetic Variability of Circulating Influenza B Viruses in Uruguay, 2012–2019
Rivas, M. J., Alegretti, M. A., Cóppola, L., Ramas, V., Chiparelli, H., & Goñi, N. (2020) · Microorganisms · doi:10.3390/microorganisms8040591 · Cited by 13
Deng, Y., Iannello, P., Caldwell, N., Jelley, L., Komadina, N., Baas, C., Kelso, A., & Barr, I. (2013) · Journal of Clinical Virology · doi:10.1016/j.jcv.2013.04.018 · Cited by 13
Passage in egg culture is a major cause of apparent positive selection in influenza B hemagglutinin
Gatherer, D. (2009) · Journal of Medical Virology · doi:10.1002/jmv.21648 · Cited by 13
Hygiene, J. O. P. M. A. (2021) · PubMed Central · doi:10.15167/2421-4248/jpmh2021.62.2s1 · Cited by 14
Blümel, J., Burger, R., Drosten, C., Gröner, A., Gürtler, L. G., Heiden, M., Hildebrandt, M., Jansen, B., Klamm, H., Montag-Lessing, T., et al. (2007) · Transfusion Medicine and Hemotherapy · doi:10.1159/000111480 · Cited by 13
Nakao, H., Nakajima, K., & Nakajima, S. (1993) · Journal of General Virology · doi:10.1099/0022-1317-74-8-1667 · Cited by 13
Matthys, A., Félix, J., Catani, J. P. P., Roose, K., Nerinckx, W., Buyten, B. V., Fijałkowska, D., Callewaert, N., Savvides, S. N., & Saelens, X. (2025) · Nature Communications · doi:10.1038/s41467-025-60232-3 · Cited by 12
Antigenic alteration of 2017-2018 season influenza B vaccine by egg-culture adaption
Wilson, J. L., Zhou, R., Liu, H., Rothman, R. E., Fenstermacher, K., & Pekosz, A. S. (2022) · Frontiers in Virology · doi:10.3389/fviro.2022.933440 · Cited by 12
Heider, A., Wedde, M., Dürrwald, R., Wolff, T., & Schweiger, B. (2022) · Virus Research · doi:10.1016/j.virusres.2022.198926 · Cited by 11
Metadata
- Authors
- Rota, P. A., Wallis, T. R., Harmon, M. W., Rota, J. S., Kendal, A. P., & Nerome, K.
- Affiliations
- Centers for Disease Control and Prevention (US)
- National Institute of Health Sciences (JP)
- Corresponding author
- Rota, Paul A.
- Venue
- Virology
- Publisher
- Elsevier BV
- Published
- 1990-03
- Volume
- 175
- Issue
- 1
- Pages
- 59-68
- ISSN
- 0042-6822 (ISSN-L)
- OpenAlex
- W1977461039
- Cited by
- 539
- References
- 33
- Citations by year
- 2026: 14 · 2025: 23 · 2024: 22 · 2023: 18 · 2022: 31 · 2021: 32 · 2020: 36 · 2019: 40 · 2018: 41 · 2017: 23 · 2016: 31 · 2015: 30 · 2014: 29 · 2013: 30 · 2012: 14
- FWCI
- 4.47
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Virology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Influenza Virus Research Studies
- Health Sciences › Medicine › Epidemiology › Respiratory viral infections research
- Health Sciences › Medicine › Epidemiology › Virology and Viral Diseases
- Keywords
- influenza B, co-circulation, evolutionary lineages, antigenic variants, hemagglutinin gene, hemagglutination inhibition, molecular evolution
- MeSH terms
- Amino Acid Sequence, Antigens, Viral, Base Sequence, Biological Evolution, Genes, Viral, Molecular Sequence Data, Influenza B virus, Oligonucleotide Probes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review